News
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Key Takeaways Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and ...
Barchart on MSN56m
Stocks Mixed Before Trump-Zelenskiy Meeting and Retailer Earnings
The S&P 500 Index ($SPX) (SPY) today is down by -0.03%, the Dow Jones Industrials Index ($DOWI) (DIA) is up by +0.03%, and ...
960 The Ref on MSN14m
Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs
People who are prescribed Ozempic to treat type 2 diabetes, but whose insurance does not cover it, or who don’t have ...
Novo Nordisk is working with GoodRx to offer a month’s supply of Ozempic for $499, or about half the list price, for self-paying patients. Ozempic, a drug approved for Type 2 diabetes, cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback